CN

CN
1.1
Chemistry Analysis General Introduction
2.1
Cancer Cell Panel
2.2
Clinical Virology
2.3
Diabetes Services
2.4
HBV Services
2.5
Hepatocellular Carcinoma (HCC) Models
2.6
In Vitro Early Toxicity
2.7
In Vivo Pharmacology
2.8
NASH Pharmacology Models
2.9
Mini Safety Panel
2.10
Virology brochure
3.1
Oncology Services General Introduction
3.2
Cell Line-Derived Xenograft (CDX) Tumor Models
3.3
CRISPR/Cas9 Gene Editing
3.4
Immuno-oncology Services
3.5
Patient-Derived Xenograft (PDX) Tumor Models
3.6
Translational Oncology
4.1
General Introduction of Drug Discovery Services
5.1
WuXi AppTec HitS - DELight Handbook
5.2
WuXi AppTec HitS - DELopen Handbook
5.3
WuXi AppTec HitS_DELight_flyer
5.4
WuXi AppTec HitS_DELopen
5.5
WuXi AppTec HitS_DELpro
5.6
Antibody & Protein Preparation Service
5.7
One-Stop Target-to-Hit Solutions
6.1
Introduction
6.2
PROTAC
6.3
CAR-T TCR-T
6.4
Target Discovery & Validation